{"id":80661,"date":"2025-06-07T05:22:56","date_gmt":"2025-06-07T03:22:56","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=80661"},"modified":"2025-06-07T05:22:56","modified_gmt":"2025-06-07T03:22:56","slug":"oblibeny-lek-na-hubnuti-by-mohl-zpusobit-nahlou-slepotu-uvadi-evropsky-organ-pro-dohled-nad-zdravim","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2025\/06\/07\/oblibeny-lek-na-hubnuti-by-mohl-zpusobit-nahlou-slepotu-uvadi-evropsky-organ-pro-dohled-nad-zdravim\/","title":{"rendered":"Obl\u00edben\u00fd l\u00e9k na hubnut\u00ed by mohl zp\u016fsobit n\u00e1hlou slepotu, uv\u00e1d\u00ed evropsk\u00fd org\u00e1n pro dohled nad zdrav\u00edm"},"content":{"rendered":"<div id=\"fb-root\"><\/div>\n<h3>V\u00fdrobci p\u0159\u00edpravku Ozempic bylo doporu\u010deno, aby z\u00e1va\u017en\u00e9 o\u010dn\u00ed onemocn\u011bn\u00ed uvedl jako vedlej\u0161\u00ed \u00fa\u010dinek<\/h3>\n<p data-start=\"155\" data-end=\"337\"><span>Evropsk\u00e1 agentura pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky (EMA) dosp\u011bla k z\u00e1v\u011bru, \u017ee l\u00e9ky na b\u00e1zi semaglutidu \u2013 v\u010detn\u011b p\u0159\u00edpravk\u016f Ozempic, Wegovy a Rybelsus \u2013 zvy\u0161uj\u00ed riziko z\u00e1va\u017en\u00e9ho o\u010dn\u00edho onemocn\u011bn\u00ed, kter\u00e9 m\u016f\u017ee v\u00e9st k n\u00e1hl\u00e9 ztr\u00e1t\u011b zraku.<\/span><\/p>\n<p data-start=\"155\" data-end=\"337\"><span>Po komplexn\u00edm p\u0159ezkoum\u00e1n\u00ed bezpe\u010dnosti v p\u00e1tek V\u00fdbor pro posuzov\u00e1n\u00ed rizik farmakovigilance (PRAC) agentury EMA\u00a0<\/span><a href=\"https:\/\/www.ema.europa.eu\/en\/news\/prac-concludes-eye-condition-naion-very-rare-side-effect-semaglutide-medicines-ozempic-rybelsus-wegovy\" target=\"_blank\" rel=\"noopener noreferrer\"><span>rozhodl<\/span><\/a><span>\u00a0\u00a0, \u017ee nearteritick\u00e1 p\u0159edn\u00ed ischemick\u00e1 optick\u00e1 neuropatie (NAION) by m\u011bla b\u00fdt uvedena jako\u00a0<\/span><em><span>\u201evelmi vz\u00e1cn\u00fd\u201c<\/span><\/em><span>\u00a0ne\u017e\u00e1douc\u00ed \u00fa\u010dinek semaglutidu \u2013 hlavn\u00ed slo\u017eky l\u00e9k\u016f na hubnut\u00ed a antidiabetik vyr\u00e1b\u011bn\u00fdch spole\u010dnost\u00ed Novo Nordisk.<\/span><\/p>\n<p data-start=\"886\" data-end=\"1183\"><span>P\u0159ezkum proveden\u00fd org\u00e1nem EU pro dohled nad zdrav\u00edm, zah\u00e1jen\u00fd v lednu 2025, analyzoval data z klinick\u00fdch studi\u00ed, postmarketingov\u00e9ho sledov\u00e1n\u00ed a l\u00e9ka\u0159sk\u00e9 literatury. Zji\u0161t\u011bn\u00ed nazna\u010duj\u00ed, \u017ee dosp\u011bl\u00ed s diabetem 2. typu u\u017e\u00edvaj\u00edc\u00ed semaglutid maj\u00ed p\u0159ibli\u017en\u011b dvojn\u00e1sobn\u00e9 riziko vzniku neinvazivn\u00ed invazivn\u00ed osteoartr\u00f3zy (NAION) ve srovn\u00e1n\u00ed s t\u011bmi, kte\u0159\u00ed l\u00e9k neu\u017e\u00edvaj\u00ed. Klasifikace ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f\u00a0<\/span><em><span>\u201evelmi vz\u00e1cn\u00e9\u201c<\/span><\/em><span>\u00a0\u00a0nazna\u010duje, \u017ee tento stav m\u016f\u017ee postihnout a\u017e 1 z 10 000 u\u017eivatel\u016f.<\/span><\/p>\n<p data-start=\"1185\" data-end=\"1436\"><span>NAION je druhou nej\u010dast\u011bj\u0161\u00ed p\u0159\u00ed\u010dinou slepoty souvisej\u00edc\u00ed s optick\u00fdm nervem po glaukomu. Pacient\u016fm, u kter\u00fdch se b\u011bhem u\u017e\u00edv\u00e1n\u00ed semaglutidu objev\u00ed n\u00e1hl\u00e1 ztr\u00e1ta zraku nebo rychl\u00e9 zhor\u0161en\u00ed zraku, se doporu\u010duje, aby v p\u0159\u00edpad\u011b diagn\u00f3zy NAION okam\u017eit\u011b vyhledali l\u00e9ka\u0159skou pomoc a p\u0159eru\u0161ili u\u017e\u00edv\u00e1n\u00ed.<\/span><\/p>\n<p data-start=\"1709\" data-end=\"1993\"><span>D\u00e1nsk\u00e1 spole\u010dnost Novo Nordisk vlastn\u00ed patent na semaglutid, agonistu receptoru GLP-1 pou\u017e\u00edvan\u00e9ho k l\u00e9\u010db\u011b diabetu 2. typu a obezity. Funguje tak, \u017ee zvy\u0161uje sekreci inzul\u00ednu a podporuje pocit sytosti, \u010d\u00edm\u017e pom\u00e1h\u00e1 kontrolovat hladinu cukru v krvi a regulovat hmotnost.<\/span><\/p>\n<p data-start=\"1995\" data-end=\"2413\"><span>Ned\u00e1vn\u00e1 studie rovn\u011b\u017e nazna\u010dila, \u017ee Ozempic a podobn\u00e9 l\u00e9ky mohou zvy\u0161ovat riziko\u00a0<\/span><a href=\"https:\/\/www.rt.com\/news\/618641-weight-loss-drug-cancer\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span>rakoviny ledvin<\/span><\/a><span>\u00a0. L\u00e9ky v\u0161ak \u00fadajn\u011b sni\u017euj\u00ed riziko v\u00edce ne\u017e tuctu dal\u0161\u00edch druh\u016f rakoviny, co\u017e nazna\u010duje, \u017ee jejich celkov\u00fd p\u0159\u00ednos m\u016f\u017ee st\u00e1le p\u0159eva\u017eovat nad riziky. Agentura EMA nav\u00edc d\u0159\u00edve vy\u0161et\u0159ovala zpr\u00e1vy o sebevra\u017eedn\u00fdch my\u0161lenk\u00e1ch spojen\u00fdch s u\u017e\u00edv\u00e1n\u00edm semaglutidu, a\u010dkoli nebyla stanovena \u017e\u00e1dn\u00e1 definitivn\u00ed kauz\u00e1ln\u00ed souvislost.<\/span><\/p>\n<p data-start=\"2415\" data-end=\"2782\" data-is-last-node=\"\" data-is-only-node=\"\"><span>Doporu\u010den\u00ed agentury EMA nyn\u00ed p\u0159ezkoum\u00e1 V\u00fdbor pro hum\u00e1nn\u00ed l\u00e9\u010div\u00e9 p\u0159\u00edpravky (CHMP), ne\u017e Evropsk\u00e1 komise p\u0159ijme kone\u010dn\u00e9 rozhodnut\u00ed. Spole\u010dnost Novo Nordisk, kter\u00e1 byla za\u010d\u00e1tkem tohoto roku sesazena z tr\u016fnu jako\u00a0<\/span><a href=\"https:\/\/www.rt.com\/business\/582256-lvmh-novo-nordisk-market-value\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span>nejhodnotn\u011bj\u0161\u00ed evropsk\u00e1 spole\u010dnost<\/span><\/a><span>\u00a0, ozn\u00e1mila sv\u016fj z\u00e1vazek k bezpe\u010dnosti pacient\u016f a spolupracuje s agenturou EMA na odpov\u00eddaj\u00edc\u00ed aktualizaci ozna\u010den\u00ed produkt\u016f.<\/span><\/p>\n<p data-start=\"2415\" data-end=\"2782\" data-is-last-node=\"\" data-is-only-node=\"\"><img decoding=\"async\" loading=\"lazy\" class=\"alignnone size-full wp-image-1185\" src=\"http:\/\/www.infokuryr.cz\/n\/wp-content\/uploads\/2021\/04\/kuryr-podpis.png\" alt=\"\" width=\"84\" height=\"24\" \/><\/p>\n<p data-start=\"2415\" data-end=\"2782\" data-is-last-node=\"\" data-is-only-node=\"\">\n","protected":false},"excerpt":{"rendered":"<p>V\u00fdrobci p\u0159\u00edpravku Ozempic bylo doporu\u010deno, aby z\u00e1va\u017en\u00e9 o\u010dn\u00ed onemocn\u011bn\u00ed uvedl jako vedlej\u0161\u00ed \u00fa\u010dinek Evropsk\u00e1 agentura&#8230;<\/p>\n","protected":false},"author":2,"featured_media":63625,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[6220,1453,8596,9270],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/80661"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=80661"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/80661\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/63625"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=80661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=80661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=80661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}